| Date | Time | Source | |
| 03/18/2010 | 5:00PM | PRNUS | Haemonetics Announces Agreement to License Alba Blood Typing Reagents
Haemonetics Corporation (NYSE: HAE), a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. This arrangement provides Haemonetics with exclusive access to... More...>> |
| 03/18/2010 | 7:00AM | PRNUS | Haemonetics Corporation Announces Extension of Tender Offer for Global Med Technologies, Inc.
Haemonetics Corporation (NYSE: HAE) today announced that it is extending its previously announced cash tender offer, through its wholly-owned subsidiary Atlas Acquisition Corp., for all outstanding shares of common and preferred stock of Global Med Technologies, Inc., until 12:00 midnight, Boston, Massachusetts time, on... More...>> |
| 02/22/2010 | 12:26PM | PRNUS | FDA Clears Haemonetics 510(k) to Collect 2RBC from More Female Donors
On January 27, 2010 the FDA cleared the Haemonetics (NYSE:HAE) 510(k) for its expanded nomogram to collect two Red Blood Cells on the Cymbal® Automated Blood Collection System from female donors who are at least 150 pounds and are 63 inches in height. The Cymbal is a small, portable, battery operated instrument that automates... More...>> |
| 02/01/2010 | 8:30AM | PRNUS | Haemonetics Reports Double Digit Growth in Earnings Per Share for Third Quarter Fiscal 2010
Haemonetics Corporation (NYSE:HAE) reported third quarter GAAP net revenues of $165 million, up 6%, net income of $18 million, up 13%, and earnings per share of $0.71, up 13%. Year-to-date, Haemonetics' GAAP net revenues are $476 million, up 7%; net income is $54 million, up 20%; and earnings per share are $2.08, up 20... More...>> |
| 02/01/2010 | 8:30AM | PRNUS | Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
Haemonetics Corporation (NYSE:HAE) and Global Med Technologies, Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) today announced a definitive agreement under which Haemonetics will acquire Global Med for approximately $60 million in a cash tender offer. As a global leader in blood management solutions, Haemonetics helps plasma fractionators... More...>> |
| 02/01/2010 | 8:30AM | PRNUS | Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
Haemonetics Corporation (NYSE:HAE) and Global Med Technologies, Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) today announced a definitive agreement under which Haemonetics will acquire Global Med for approximately $60 million in a cash tender offer. As a global leader in blood management solutions, Haemonetics helps plasma fractionators... More...>> |
| 01/12/2010 | 5:00PM | PRNUS | Haemonetics Sets Date For Third Quarter Fiscal Year 2010 Earnings Release: February 1, 2010
Haemonetics Corporation (NYSE:HAE) will announce its Q3FY10 earnings on February 1, 2010 in a pre-market press release and 10:00 am (EST) webcast. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID= 2662404 Webcast replay will be available from February 1, 2010 after 1:00 pm to... More...>> |
| 01/04/2010 | 5:00PM | PRNUS | Haemonetics to Present at J.P. Morgan Healthcare Conference
Haemonetics Corporation (NYSE:HAE) announced today that Brian Concannon, Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2010 at 11:30 am Pacific time. The public may access Mr. Concannon's presentation live via webcast at http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=HAE... More...>> |
| 12/15/2009 | 4:47PM | PRNUS | Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
Fenwal Inc., a global leader focused on improving blood collection, safety and availability for patient care, reiterated its commitment to provide blood centers with Alyx® system supplies needed to collect lifesaving blood products, despite a new lawsuit filed yesterday against Fenwal by Haemonetics Corporation (NYSE:HAE... More...>> |
| 12/14/2009 | 5:11PM | PRNUS | Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement
Haemonetics Corporation (NYSE:HAE) announced today that it has filed a new legal action to stop Fenwal Inc.'s continued patent infringement resulting from Fenwal's just released red cell collection kits, using a modified separation chamber. Fenwal allegedly modified its separation chamber to circumvent Haemonetics' patent... More...>> |
| 11/02/2009 | 8:00AM | PRNUS | Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010
Haemonetics Corporation (NYSE:HAE) reported second quarter GAAP net revenues of $157 million, up 8%, net income of $18 million, up 22%, and earnings per share of $0.69, up 20%. Year-to-date, Haemonetics' GAAP net revenues are $311 million, up 7%; net income is $36 million, up 24%; and earnings per share are $1.37, up 24... More...>> |
| 10/26/2009 | 8:30AM | PRNUS | Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
Haemonetics Corporation (NYSE:HAE) announced today that Dr. Mark Popovsky, Vice President and Chief Medical Officer, has been awarded the Emily Cooley Memorial Award and Lectureship by AABB. The Memorial Award was founded as a lectureship in 1963 and is given annually to a person who has demonstrated teaching ability and... More...>> |
| 10/16/2009 | 8:30AM | PRNUS | Haemonetics Sets Date for Second Quarter Fiscal Year 2010 Earnings Release: November 2, 2009
Haemonetics Corporation (NYSE:HAE) will announce its Q2FY10 earnings on November 2, 2009 in a pre-market press release and 10:00 am (EST) webcast. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID= 2486290 Webcast replay will be available from November 2, 2009 after 1:00 pm to... More...>> |
| 08/03/2009 | 8:00AM | PRNUS | Haemonetics Reports Double Digit Growth in Earnings for First Quarter Fiscal 2010
Haemonetics Corporation (NYSE:HAE) reported first quarter GAAP net revenues of $154 million, up 7%; net income of $18 million, up 26%, and earnings per share of $0.69, up 28%. Excluding restructuring charges in fiscal 2009 which did not recur in fiscal 2010, adjusted first quarter net income growth was 16%, and adjusted... More...>> |
| 07/13/2009 | 8:30AM | PRNUS | Haemonetics Sets Date for First Quarter Fiscal Year 2010 Earnings Release: August 3, 2009
Haemonetics Corporation (NYSE:HAE) will announce its Q1FY10 earnings on August 3, 2009 in a pre-market press release and 10:00 am (EDT) webcast. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID= 2323195 Webcast replay will be available from August 3, 2009 after 1:00 pm to August... More...>> |
| 06/04/2009 | 9:33AM | PRNUS | Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
Haemonetics Corporation (NYSE:HAE) announced today that the U.S. District Court for the District of Massachusetts has made a ruling in the Company's lawsuit against Fenwal, Inc. In January 2009, a jury issued a verdict in favor of Haemonetics, finding that Fenwal's ALYX Component Collection System consumable infringes... More...>> |
| 05/04/2009 | 4:45PM | PRNUS | Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees
Haemonetics Corporation (NYSE:HAE) today reported record revenues and earnings for fiscal 2009 and its eighth consecutive quarter of double digit revenue growth. For the year, Haemonetics reported GAAP net revenues of $598 million, up 16%; operating income of $86 million, up 22%; net income of $59 million, up 14%; and... More...>> |
| 05/04/2009 | 8:00AM | PRNUS | Haemonetics Reports Strong Double Digit Growth in Revenue, Net Income, and EPS for Fiscal 2009 and Issues Guidance for Continued
Haemonetics Corporation (NYSE:HAE) today reported record revenues and earnings for fiscal 2009 and its eighth consecutive quarter of double digit revenue growth. The Company also announced fiscal 2010 guidance, including continued double digit growth in earnings. For the year, Haemonetics reported GAAP net revenues of... More...>> |
| 04/28/2009 | 8:30AM | PRNUS | Haemonetics Sets Date For Fourth Quarter Fiscal Year 2009 Earnings Release: May 4, 2009
Haemonetics Corporation (NYSE:HAE) will announce its Q4FY09 earnings on May 4, 2009 in a pre-market press release and 10:00 am (EDT) webcast. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&even tID=2195077 Webcast replay will be available from May 4, 2009 after 1:00 pm to May 11, 2009... More...>> |
| 04/22/2009 | 8:45AM | PRNUS | Haemonetics Sets Date for Investor/Analyst Meeting
Haemonetics Corporation announced today that it will host its annual investor and analyst day on Thursday, May 14th from 10:00 am to 12:30 pm at its corporate headquarters in Braintree, Massachusetts. The agenda for the meeting includes: -- Fiscal 2010 Annual Operating Plan Review -- Plasma Market Trends -- Blood Management... More...>> |